Germany Plans to Ban Disposable E-Cigarettes

Mar.21.2023
Germany Plans to Ban Disposable E-Cigarettes
Germany plans to ban disposable e-cigarettes due to environmental concerns, with the support of the Federal Environment Minister.

The German Federal Senate has recently developed a plan to ban disposable electronic cigarettes. The plan aims to prohibit disposable e-cigarettes throughout Germany, with the Senate currently urging the federal government to consider implementing the ban. Steffi Lemke, the German Federal Environment Minister, has expressed support for the resolution.


The pressing issue of environmental pollution that needs to be addressed.


Currently, over 5 million disposable e-cigarettes are sold every month in Germany, according to data from the German E-cigarette Trade Association (VdeH). The sales revenue of e-cigarettes in the Federal Republic of Germany is expected to exceed 300 million euros by 2022. E-cigarettes are now commonly sold in supermarkets and convenience stores (Spätis), priced between 7 and 10 euros, and can provide up to 600 puffs for users.


After using disposable e-cigarettes, waste materials such as electronic waste, plastic waste, and used batteries are produced, posing environmental pollution problems. Environmentalists heavily criticize disposable e-cigarettes and condemn the huge waste of resources they cause. The e-liquid inside the device is actually heated by electricity, but lithium-ion batteries are highly flammable, which hinders their recycling.


According to sources from 2FIRSTS, German Federal Environment Minister Svenja Schulze, who supports this resolution, is a member of the Green Party (GRÜNE). The Green Party is an environmental protection-focused political party and the world's oldest green political organization. They advocate for green politics, oppose military expansion, promote peace and anti-nuclear energy, and promote a return to a natural lifestyle.


According to a previous report by 2FIRSTS, Linda Heitmann, a member of the German Green Party, proposed restricting the supply of alcohol and cigarettes, citing them as "the most dangerous drugs to date." Gillian Mackay, a member of the Scottish Green Party, hoped that retailers would treat e-cigarettes like cigarettes and "hide" them from view.


According to reports, in January 2023, the government of the Bavarian state of Germany called for a ban on electronic cigarettes within the European Union and requested that the federal government initiate a movement at the EU level to prohibit the sale of disposable electronic cigarette products. The Bavarian state hopes to reduce the market growth of disposable electronic cigarette products and ultimately decrease the environmental pollution caused by related products through government advocacy.


Teenagers are starting to engage in the trend of using drugs.


In the past year, there has been a significant increase in the number of 14 to 17 year-olds in Germany using e-cigarettes. In a recent representative survey, 15.9% of adolescents in Germany admitted to smoking.


The nicotine levels in electronic cigarettes may be higher than those in traditional cigarettes. Christina Schadt, head of the addiction prevention organization Suchtprävention Berlin, told Stern: "Young people who have not yet smoked are learning about smoking through these products. The sweet taste and smoothness of e-cigarettes give them a false impression that they are consuming something harmless.


Further reading:


The German Green Party proposed restrictions on the sale of tobacco and alcohol.


The era of strict regulation for electronic cigarettes has arrived in Germany. Multiple shops are being inspected.


Reference:


Germany is considering banning disposable e-cigarettes in the near future.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
UK HMRC Launches Vape Duty Stamps on October 1, Ushering in Supply-Chain Traceability as Chinese Exporters Face New Compliance Hurdles
HM Revenue & Customs put the UK's Vaping Products Duty and Vaping Duty Stamps Scheme into effect on October 1. All vaping liquids manufactured in or imported into the UK are now subject to duty at £2.20 per 10ml, regardless of nicotine content. The stamp regime will introduce digital functionality designed to provide traceability throughout the supply chain, with approved manufacturers, importers and warehousekeepers required to report product movements and retailers and consumers eventually able to scan stamps to verify authenticity. China exported $177 million of vape-related products to the UK in August, up 51.4% year over year, increasing the significance of the new compliance regime for China's Shenzhen-centered vape supply chain.
Regulations
Oct.04
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands Sees Double-Digit NGP Growth as Sixth Year of Tobacco Revenue Gains Backs £1.5 Billion Buyback
Imperial Brands reaffirmed its FY26 guidance in its October 8 pre-close trading update, forecasting double-digit net revenue growth in next-generation products and share gains across heated tobacco, vape and modern oral. Tobacco net revenue is expected to grow at a low-single-digit rate, marking a sixth consecutive year of growth. The company has completed its £1.45 billion FY26 share repurchase and announced a £1.5 billion buyback for FY27. Group adjusted operating profit is expected to increase 3% to 5%, while free cash flow is forecast to exceed £2.2 billion.
Oct.09
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Product | Japan Tobacco Expands Nordic Spirit Nicotine Pouch Range to Eight SKUs in Japan, Launches Melon Variant and Broadens Mint Retail Distribution
Japan Tobacco Inc. (JT) launched Nordic Spirit Rich Melon Medium through selected tobacco retailers in Japan on November 2, 2026, while expanding physical retail distribution for three existing mint products previously sold through the CLUB JT online store. The melon launch brings Nordic Spirit's Japanese portfolio to eight SKUs. All four products are manufactured in Sweden, contain a standard 14 pouches per can and retail for ¥500 including tax. Since introducing Nordic Spirit in Japan in March, JT has expanded the brand's product lineup and distribution through its online store, convenience stores and selected tobacco retailers.
product
Nov.04
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Special Report | Can Nicotine Be Replaced? 6-MN Is Already on the Market While Key Human Evidence Is Still Missing
Nicotine analogues such as 6-methylnicotine are already appearing in e-cigarettes and oral pouches, even as key human evidence remains limited. A new Nixodine-S study adds nonclinical data showing differences from nicotine in cytotoxicity and receptor activity, while independent studies point to a more complex toxicological picture. With supply-chain activity growing and FDA seeking clearer authority over nicotine analogues, the industry now faces a larger question: what evidence is needed before these substances can credibly replace nicotine?
SCIENCE
Sep.23